Pharmaceutical micronutrient composition and its use to simultaneously improve nervous system function, cognitive ability and response to stressors
A pharmaceutical composition of micronutrients were tried to improve brain health and nervous system functions. Various combinations of formulas were used. Formulas 12, 10 and 5 shows multiple simultaneous positive effects in supporting key functions in cells building our nervous system essential for optimum mental health including protecting nervous system cells against various damaging factors, increasing ATP production, stimulating mitochondria biogenesis, increasing mitochondrial membrane potential, increasing mitochondrial functions (Complex I activity), exhibiting anti-inflammatory capacity and increased BDNF secretion.
1. A pharmaceutical micronutrient composition, comprising: A L-theanine in the range of 0.1 mg to 10,000 mg, a Rhodiola rosea in the range of 1 mg to 10,000 mg, a Acetyl L-Carnitine in the range of 0.1 mg to 10,000 mg, Bacopa monnieri in the range of 1 mg to 10,000 mg, Mucuna pruriens in the range of 1 mg to 50,000 mg, NAD+ in the range of 0.1 mg to 20,000 mg, Rose hips extract in the range of 5 mg to 10,000 mg, American Ginseng in the range of 1 mg to 50,000 mg, Pyrroloquinoline quinone in the range of 0.1 mg to 50,000 mg, a Gotu Kola in the range of 1 mg to 50,000 mg, Avena sativa in the range of 1 mg to 50,000 mg and CoQ10 in the range of 0.01 mg to 20,000 mg.
2. The pharmaceutical micronutrient composition of claim 1 , wherein the Rhodiola rosea is from natural source as a whole plant, an extract or a combination thereof, Bacopa monnieri is from natural source as a whole plant, an extract or a combination thereof, Mucuna pruriens is from natural source as a whole plant, an extract or a combination thereof, Rose hips from natural source as a whole plant, an extract or a combination thereof, American Ginseng is from natural source as a whole plant, an extract or a combination thereof, Gotu Kola is from natural source as a whole plant, an extract or a combination thereof, Avena sativa is from natural source as a whole plant, an extract or a combination thereof.
3. The pharmaceutical micronutrient composition of claim 1 , wherein the L-theanine is from natural source as a whole plant and synthetic source, Acetyl L-Carnitine is from a natural source and synthetic source, NAD is from a natural source and synthetic source, Pyrroloquinoline quinone is from a natural source and synthetic source, Coenzyme Q10 is from a natural source and synthetic source.
4. The pharmaceutical micronutrient composition according to claim 1 , wherein the pharmaceutical micronutrient composition is used for a treatment of cognitive impairments, depression and other nervous system problems in the human and other species.
5. The pharmaceutical micronutrient composition according to claim 4 , wherein a cognitive impairment is linked to mitochondrial dysfunction.
6. The pharmaceutical micronutrient composition according to claim 4 , wherein a cognitive impairment is linked to dysfunction in BDNF secretion.
7. The pharmaceutical micronutrient composition according to claim 4 , wherein a cognitive impairment is linked to exposure to excessive stress due to a mental and a chemical condition.
8. The pharmaceutical micronutrient composition according to claim 1 , wherein the pharmaceutical micronutrient composition is used for maintaining healthy function of the nervous system in the human and other species.
9. The pharmaceutical micronutrient composition according to claim 1 , wherein the pharmaceutical micronutrient composition is used for preventing and mitigating the decline in cognitive and behavioral abilities due to age and other external and internal factors.